Literature DB >> 365215

The differentiation of myeloid leukaemia cells: new possibilities for therapy.

L Sachs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365215     DOI: 10.1111/j.1365-2141.1978.tb05826.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  21 in total

1.  IL-12 could induce monocytic tumor cells directional differentiation.

Authors:  Ting-Ting Ma; Bi-Tao Wu; Yan Lin; Hai-Yu Xiong; Qin Wang; Zi-Wei Li; Feng Cheng; Zhi-Guang Tu
Journal:  Mol Cell Biochem       Date:  2015-01-07       Impact factor: 3.396

2.  The nature and evolving treatment of myelodysplastic syndromes.

Authors:  P Greenberg
Journal:  West J Med       Date:  1989-08

3.  Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes.

Authors:  M Murray; P Sarsfield; E Lawlor; S R McCann
Journal:  Ir J Med Sci       Date:  1988-07       Impact factor: 1.568

4.  Effect of cytidine analogs on cell growth and differentiation on a human neuroblastoma line.

Authors:  S Bartolucci; M Estenoz; V de Franciscis; P Carpinelli; G L Colucci; G Augusti Tocco; M Rossi
Journal:  Cell Biophys       Date:  1989 Aug-Oct

Review 5.  The toxicity of cytarabine.

Authors:  J Stentoft
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

6.  Clinical trial of low-dose Ara-C in the treatment of acute leukemia and myelodysplasia.

Authors:  U Jehn; R De Bock; C Haanen
Journal:  Blut       Date:  1984-05

7.  Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Authors:  H J Weh; R Zschaber; D K Hossfeld
Journal:  Blut       Date:  1984-04

8.  In vitro exposure of leukemic cells to low concentration Arabinosyl Cytosine: no evidence of differentiation inducing activity.

Authors:  M R Motta; M Baccarani; S Rizzi; R Fanin; G Fasola; C Poluzzi; S Tura
Journal:  Blut       Date:  1987-05

9.  Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.

Authors:  R Ohno; K Kimura; K Ota; Y Miura; A Hoshino; K Hattori; M Hirano; M Ito; T Maekawa; T Nakamura
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

10.  Decomposition of gene expression state space trajectories.

Authors:  Jessica C Mar; John Quackenbush
Journal:  PLoS Comput Biol       Date:  2009-12-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.